<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Right <z:e sem="disease" ids="C0008513" disease_type="Disease or Syndrome" abbrv="">chorioretinitis</z:e> and bilateral <z:hpo ids='HP_0000538'>pseudopapilledema</z:hpo> were firstly appreciated in a 9-month-old child with neonatal findings of aseptic <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0001287'>meningitis</z:hpo>, framed in the context of <z:e sem="disease" ids="C0409818" disease_type="Disease or Syndrome" abbrv="CINCA">CINCA syndrome</z:e> at 1 year </plain></SENT>
<SENT sid="1" pm="."><plain>Therapeutical response to various combinations of drugs was inconsistent until 7 years, when anakinra was started with immediate clinical and laboratory improvement </plain></SENT>
<SENT sid="2" pm="."><plain>A state of severe <z:hpo ids='HP_0000556'>retinal dystrophy</z:hpo> of post-inflammatory origin became evident on funduscopy, optical coherence tomography and visual electrophysiology tests at the age of 10 years, which remained stationary after 1 year of anakinra treatment </plain></SENT>
</text></document>